KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) EBIT Margin: 2020-2025

Historic EBIT Margin for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to -231.78%.

  • Ginkgo Bioworks Holdings' EBIT Margin fell 16979.00% to -231.78% in Q3 2025 from the same period last year, while for Sep 2025 it was -192.76%, marking a year-over-year increase of 9826.00%. This contributed to the annual value of -246.54% for FY2024, which is 9722.00% up from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its EBIT Margin stood at -231.78% for Q3 2025, which was down 75.42% from -132.13% recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' EBIT Margin's 5-year high stood at -34.37% during Q3 2021, with a 5-year trough of -1,134.55% in Q4 2021.
  • Over the past 3 years, Ginkgo Bioworks Holdings' median EBIT Margin value was -236.29% (recorded in 2024), while the average stood at -294.29%.
  • In the last 5 years, Ginkgo Bioworks Holdings' EBIT Margin crashed by 96,021bps in 2021 and then surged by 89,966bps in 2022.
  • Ginkgo Bioworks Holdings' EBIT Margin (Quarterly) stood at -1,134.55% in 2021, then skyrocketed by 89,966bps to -234.89% in 2022, then slumped by 27,760bps to -512.49% in 2023, then surged by 27,620bps to -236.29% in 2024, then tumbled by 16,979bps to -231.78% in 2025.
  • Its EBIT Margin was -231.78% in Q3 2025, compared to -132.13% in Q2 2025 and -184.13% in Q1 2025.